George Makar
Company: Food and Drug Administration
Job title: Medical Officer
Seminars:
Drug Development for NASH: A Regulatory Perspective 8:00 am
• Understanding the importance of early clinical development and proof-of-concept trials • Describing the rationale for the choice of the surrogate endpoint reasonably likely to predict clinical benefit • Identifying the endpoints used to characterize the confirmation of clinical benefitRead more
day: Day Two